ribavirin has been researched along with Acute Lymphoid Leukemia in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (28.57) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Gorczyńska, E; Jarmoliński, T; Kałwak, K; Matkowska-Kocjan, A; Olejnik, I; Rosa, M; Ussowicz, M | 1 |
Barrett, JS; Borden, KLB; Carroll, AJ; Carroll, MP; Chen, IL; Culjkovic-Kraljacic, B; Davenport, JW; Devidas, M; Dreyer, ZE; Felix, CA; Harvey, RC; Heerema, NA; Hilden, JM; Hunger, SP; Jin, S; Moore, JS; Porazzi, P; Robinson, BW; Seif, AE; Tasian, SK; Teachey, DT; Urtishak, KA; Vincent, TL; Wang, LS; Willman, CL | 1 |
Derniame, S; Gaspar, HB; Gilmour, K; Hiwarkar, P; Ip, W; McNicol, AM; Qasim, W; Veys, P; Zhan, H | 1 |
Gong, Y; Len, Y; Naren, D; Shi, F; Shi, R; Yan, T; Yang, X | 1 |
Bonney, D; Razali, H; Turner, A; Will, A | 1 |
Aisa, Y; Kato, J; Mori, T; Nakamura, Y; Okamoto, S; Takeshita, K; Yamane, A | 1 |
Abe, S; Kasai, M; Kitaori, K; Kodera, Y; Miyamura, K; Oba, T; Sasaki, T; Terakura, S | 1 |
Guardo, P; La Spina, M; Lo Nigro, L; Mirabile, E; Pisana, P; Schilirò, G | 1 |
Dogan, S; Gulec, S; Nuhoglu, A; Urganci, N | 1 |
Bellini, WJ; Mustafa, MM; Siegel, JD; Timmons, CF; Weitman, SD; Winick, NJ | 1 |
Bergin, M; De Silva, LM; McCarthy, AJ; Stevens, M | 1 |
Saarinen, UM; Ukkonen, P; Vettenranta, K | 1 |
Higashi, MK; Phillips, KA; Veenstra, DL | 1 |
Engeler, GP; Hoffman, R; Jayaram, HN; Kneebone, P; Lapis, E; Paulik, E; Tricot, G; Weber, G; Zhen, W | 1 |
1 review(s) available for ribavirin and Acute Lymphoid Leukemia
Article | Year |
---|---|
Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature.
Topics: Adult; Base Sequence; Child, Preschool; Encephalitis; Female; Hemophilia A; HIV Infections; Humans; Immunocompromised Host; Male; Measles; Measles virus; Molecular Sequence Data; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribavirin; Time Factors | 1993 |
1 trial(s) available for ribavirin and Acute Lymphoid Leukemia
Article | Year |
---|---|
Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Antigens, Viral; Antiviral Agents; Capsid Proteins; Child; Chromatography, Liquid; Cidofovir; Combined Modality Therapy; Cytosine; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Immunomagnetic Separation; Immunosuppressive Agents; Immunotherapy, Adoptive; Infant; Infant, Newborn; Interferon gamma Receptor; Interferon-gamma; Lymphocyte Transfusion; Organophosphonates; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Interferon; Ribavirin; T-Cell Antigen Receptor Specificity; T-Lymphocyte Subsets; Transplantation, Homologous; Viremia | 2013 |
12 other study(ies) available for ribavirin and Acute Lymphoid Leukemia
Article | Year |
---|---|
SARS-CoV-2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation-A case report.
Topics: Anemia, Aplastic; Bone Marrow; Child; COVID-19; COVID-19 Drug Treatment; Female; Hematopoietic Stem Cell Transplantation; Humans; Metapneumovirus; Pneumonia, Viral; Postoperative Period; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; SARS-CoV-2; Transplantation, Homologous | 2021 |
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
Topics: Cell Line, Tumor; Child, Preschool; Drug Resistance, Neoplasm; Eukaryotic Initiation Factor-4E; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Indoles; Infant; Microarray Analysis; Molecular Targeted Therapy; Multigene Family; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Biosynthesis; Pyrroles; Ribavirin; Signal Transduction | 2019 |
Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Intracellular Signaling Peptides and Proteins; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Serine-Threonine Kinases; Ribavirin; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Child, Preschool; Combined Modality Therapy; Daunorubicin; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Metapneumovirus; Methotrexate; Paramyxoviridae Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Ribavirin; Vincristine | 2009 |
Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
Topics: Antiviral Agents; Bronchiolitis Obliterans; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Transplantation, Homologous | 2011 |
Oral ribavirin for severe adenovirus infection after allogeneic marrow transplantation.
Topics: Adenoviridae Infections; Administration, Oral; Adult; Bone Marrow Transplantation; Cystitis; Humans; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribavirin; Transplantation, Homologous | 2003 |
Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL.
Topics: Antiviral Agents; Child, Preschool; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Ribavirin | 2004 |
Interferon and ribavirin treatment results of patients with HBV-HCV co-infection cured of childhood malignancies.
Topics: Adolescent; Alanine Transaminase; Antiviral Agents; Child; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Hepacivirus; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis C; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2006 |
Intravenous ribavirin therapy for disseminated adenovirus infection.
Topics: Adenovirus Infections, Human; Antiviral Agents; Fever of Unknown Origin; Humans; Immunocompromised Host; Infant; Injections, Intravenous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribavirin | 1995 |
RSV infection complicating the therapy of pediatric malignancies: report of six cases.
Topics: Antineoplastic Agents; Antiviral Agents; Bone Marrow Transplantation; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Male; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Respiratory Syncytial Virus Infections; Ribavirin | 1996 |
Assessing the cost-effectiveness of pharmacogenomics.
Topics: Anticholesteremic Agents; Anticoagulants; Antimetabolites, Antineoplastic; Cardiovascular Diseases; Carrier Proteins; Child; Cholesterol Ester Transfer Proteins; Cost-Benefit Analysis; Drug Therapy; Genotype; Glycoproteins; Hepatitis C; Humans; Interferons; Mercaptopurine; Methyltransferases; Pharmacogenetics; Pharmacology, Clinical; Phenotype; Pravastatin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribavirin; Warfarin | 2000 |
Clinical pharmacokinetic study of tiazofurin administered as a 1-hour infusion.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blast Crisis; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribavirin | 1992 |